Encouraged by the tumour eradication obtained in subcutaneous xenografts, we studied the therapeutic performance of F16–IL2 and temozolomide in an intracranial model of glioblastoma, obtained by stereotactic injection of 5 × 104 U87MG cells into nude mice. The gene discussed is IL2; the disease is glioblastoma.